LncRNA CALML3-AS1 modulated by m6A modification induces BTNL9 methylation to drive non-small-cell lung cancer

Heng Zhang1,2,3, Shao-Qiang Wang4,5, Jie-Bo Zhu6

  • 1Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan Province, P. R. China. 404346@csu.edu.cn.

Cancer Gene Therapy
|October 26, 2023
PubMed

Insights

Long non-coding RNA CALML3-AS1 promotes non-small cell lung cancer (NSCLC) progression. It enhances tumor growth and metastasis by epigenetically silencing BTNL9, modulated by m6A modification.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Non-small Cell Lung Cancer (NSCLC) Research

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
  • The long non-coding RNA CALML3 antisense RNA 1 (CALML3-AS1) has been implicated in carcinogenesis, but its precise role and mechanisms in NSCLC require further elucidation.

Purpose of the Study:

  • To investigate the functional role of CALML3-AS1 in NSCLC progression.
  • To elucidate the underlying molecular mechanisms by which CALML3-AS1 influences NSCLC pathogenesis, including its interaction with epigenetic regulators and target genes.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and Western blot for gene expression analysis.
  • Fluorescence in situ hybridization (FISH) for subcellular localization.
  • Cellular assays (CCK-8, colony formation, EdU, wound healing, Transwell) and in vivo models (xenograft, liver metastasis) to assess malignant behaviors.
  • RNA immunoprecipitation (RIP), RNA pull-down, and chromatin immunoprecipitation (ChIP) assays to investigate molecular interactions.
  • Methylation-specific PCR (MSP) to detect methylation levels.

Main Results:

  • CALML3-AS1 was significantly upregulated, while butyrophilin-like 9 (BTNL9) was downregulated in NSCLC tissues and cells.
  • Depletion of CALML3-AS1 suppressed NSCLC cell proliferation, migration, invasion, tumor growth, and liver metastasis.
  • CALML3-AS1 stability is regulated by N6-methyladenosine (m6A) modification, with AlkB homolog 5 (ALKBH5) enhancing its stability and YTH domain-containing 2 (YTHDC2) destabilizing it.
  • CALML3-AS1 epigenetically repressed BTNL9 expression by recruiting Zeste homolog 2 (EZH2).
  • Restoration of BTNL9 expression partially rescued the antitumor effects of CALML3-AS1 knockdown.

Conclusions:

  • CALML3-AS1 acts as a crucial oncogenic lncRNA in NSCLC, promoting malignant phenotypes and metastasis.
  • The ALKBH5/m6A/YTHDC2 axis modulates CALML3-AS1 stability, influencing its oncogenic function.
  • CALML3-AS1 drives NSCLC progression by epigenetically inhibiting BTNL9, highlighting a potential therapeutic target.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K